-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
iTeos Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q2 2024.
- iTeos Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $421K, a 51.4% increase year-over-year.
- iTeos Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.42M, a 53.5% increase year-over-year.
- iTeos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.2M, a 39.7% increase from 2022.
- iTeos Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $860K, a 12.1% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)